Literature DB >> 23288584

Improving outcomes of living-donor right hepatectomy.

S H Kim1, Y K Kim.   

Abstract

BACKGROUND: Complication rates of living-donor right hepatectomy remain a matter of major concern. The aim of this study was to achieve near-zero morbidity for living-donor right hepatectomy in a single centre.
METHODS: All living donors who underwent right hepatectomy between January 2005 and September 2011 were enrolled in this retrospective study. During this interval, modifications in surgical technique and management included upper midline laparotomy, use of wound protectors, hanging manoeuvre during parenchymal transection using Glisson's approach, no intraoperative cholangiography, no intensive care unit stay after surgery, no central venous catheterization, and reduction in systemic heparin dose before graft removal. Donor characteristics, operative outcomes and complications graded according to Clavien's classification were recorded.
RESULTS: A total of 300 donors were enrolled and these were divided into three groups of 100 operated on in consecutive time periods. Groups were comparable with regard to donor characteristics. The overall complication rate was 16·0 per cent, with no deaths. From group 1 to group 3, the duration of operation (P < 0·001), length of hospital stay (P < 0·001), and rate of overall (P < 0·001) and grade IIIb (P = 0·019) complications decreased significantly. In the most recent group, the morbidity rate was 3·0 per cent without any major complications, reoperation or blood transfusions. All donors recovered completely.
CONCLUSION: This study suggests that near-zero morbidity may be reached after right hepatectomy in carefully selected living donors by continuous refinement of surgical technique and management.
Copyright © 2013 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 23288584     DOI: 10.1002/bjs.9022

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  16 in total

Review 1.  Pushing the frontiers of living donor right hepatectomy.

Authors:  Seong Hoon Kim; Seung Duk Lee; Young Kyu Kim; Sang-Jae Park
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

2.  2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma.

Authors: 
Journal:  Korean J Radiol       Date:  2015-05-13       Impact factor: 3.500

Review 3.  Controlled low central venous pressure reduces blood loss and transfusion requirements in hepatectomy.

Authors:  Zhi Li; Yu-Ming Sun; Fei-Xiang Wu; Li-Qun Yang; Zhi-Jie Lu; Wei-Feng Yu
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

4.  [Influence of bile duct anatomy on biliary complications in hepatic right lobe living donors].

Authors:  A Bauschke; A Altendorf-Hofmann; C Malessa; O Rohland; U Settmacher
Journal:  Chirurg       Date:  2018-03       Impact factor: 0.955

Review 5.  Laparoscopic liver resection for living donation: where do we stand?

Authors:  François Cauchy; Lilian Schwarz; Olivier Scatton; Olivier Soubrane
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

Review 6.  Use of robotics in liver donor right hepatectomy.

Authors:  Po-Da Chen; Chao-Yin Wu; Yao-Ming Wu
Journal:  Hepatobiliary Surg Nutr       Date:  2017-10       Impact factor: 7.293

Review 7.  Robot-Assisted Transplant Surgery - Vision or Reality? A Comprehensive Review.

Authors:  Philipp Stiegler; Peter Schemmer
Journal:  Visc Med       Date:  2018-02-07

Review 8.  2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma.

Authors: 
Journal:  Korean J Radiol       Date:  2019-07       Impact factor: 3.500

9.  2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma.

Authors: 
Journal:  Gut Liver       Date:  2019-05-15       Impact factor: 4.519

10.  2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma.

Authors: 
Journal:  Gut Liver       Date:  2015-05-23       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.